Literature DB >> 27402402

Mitochondrial complex I dysfunction and altered NAD(P)H kinetics in rat myocardium in cardiac right ventricular hypertrophy and failure.

Rob C I Wüst1, Heder J de Vries2, Liesbeth T Wintjes3, Richard J Rodenburg3, Hans W M Niessen4, Ger J M Stienen5.   

Abstract

AIMS: In cardiac hypertrophy (CH) and heart failure (HF), alterations occur in mitochondrial enzyme content and activities but the origin and implications of these changes for mitochondrial function need to be resolved. METHODS AND
RESULTS: Right ventricular CH or HF was induced by monocrotaline injection, which causes pulmonary artery hypertension, in rats. Results were compared with saline injection (CON). NAD(P)H and FAD autofluorescence were recorded in thin intact cardiac trabeculae during transitions in stimulation frequency, to assess mitochondrial complex I and complex II function, respectively. Oxygen consumption, mitochondrial morphology, protein content, and enzymatic activity were assessed. NAD(P)H autofluorescence upon an increase in stimulation frequency showed a rapid decline followed by a slow recovery. FAD autofluorescence followed a similar time course, but in opposite direction. The amplitude of the early rapid change in NAD(P)H autofluorescence was severely depressed in CH and HF compared with CON. The rapid changes in FAD autofluorescence in CH and HF were reduced to a lesser extent. Complex I-coupled respiration showed an ∼3.5-fold reduction in CH and HF; complex II-coupled respiration was depressed two-fold in HF. Western blot analyses revealed modest reductions in complex I protein content in CH and HF and in complex I activity in supercomplexes in HF. Mitochondrial volume density was similar, but mitochondrial remodelling was evident from changes in ultrastructure and fusion/fission indices in CH and HF.
CONCLUSION: These results suggest that the alterations in mitochondrial function observed in right ventricular CH and HF can be mainly attributed to complex I dysfunction. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2016. For permissions please email: journals.permissions@oup.com.

Entities:  

Keywords:  Contractile function; Heart failure; Hypertrophy; Mitochondria; Myocardium

Mesh:

Substances:

Year:  2016        PMID: 27402402     DOI: 10.1093/cvr/cvw176

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  20 in total

1.  Pulmonary arterial hypertension reduces energy efficiency of right, but not left, rat ventricular trabeculae.

Authors:  Toan Pham; Linley Nisbet; Andrew Taberner; Denis Loiselle; June-Chiew Han
Journal:  J Physiol       Date:  2018-02-25       Impact factor: 5.182

2.  Diaphragm Atrophy and Weakness in the Absence of Mitochondrial Dysfunction in the Critically Ill.

Authors:  Marloes van den Berg; Pleuni E Hooijman; Albertus Beishuizen; Monique C de Waard; Marinus A Paul; Koen J Hartemink; Hieronymus W H van Hees; Michael W Lawlor; Lorenza Brocca; Roberto Bottinelli; Maria A Pellegrino; Ger J M Stienen; Leo M A Heunks; Rob C I Wüst; Coen A C Ottenheijm
Journal:  Am J Respir Crit Care Med       Date:  2017-12-15       Impact factor: 21.405

3.  Calcium mishandling impairs contraction in right ventricular hypertrophy prior to overt heart failure.

Authors:  Amelia S Power; Anthony J Hickey; David J Crossman; Denis S Loiselle; Marie-Louise Ward
Journal:  Pflugers Arch       Date:  2018-03-10       Impact factor: 3.657

Review 4.  Early adjustments in mitochondrial structure and function in skeletal muscle to high altitude: design and rationale of the first study from the Kilimanjaro Biobank.

Authors:  G J M Stienen
Journal:  Biophys Rev       Date:  2020-06-22

Review 5.  Posttranslational modifications of mitochondrial fission and fusion proteins in cardiac physiology and pathophysiology.

Authors:  Stephanie M Adaniya; Jin O-Uchi; Michael W Cypress; Yoichiro Kusakari; Bong Sook Jhun
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-13       Impact factor: 4.249

Review 6.  Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Authors:  Maurizio Forte; Silvia Palmerio; Franca Bianchi; Massimo Volpe; Speranza Rubattu
Journal:  J Mol Med (Berl)       Date:  2019-03-12       Impact factor: 4.599

7.  The lncRNA Plscr4 Controls Cardiac Hypertrophy by Regulating miR-214.

Authors:  Lifang Lv; Tianyu Li; Xuelian Li; Chaoqian Xu; Qiushuang Liu; Hua Jiang; Yingnan Li; Yingqi Liu; He Yan; Qihe Huang; Yuhong Zhou; Mingyu Zhang; Hongli Shan; Haihai Liang
Journal:  Mol Ther Nucleic Acids       Date:  2017-12-30       Impact factor: 8.886

8.  Haemin attenuates intermittent hypoxia-induced cardiac injury via inhibiting mitochondrial fission.

Authors:  Qian Han; Guihua Li; Mary SiuMan Ip; Yuelin Zhang; Zhe Zhen; Judith ChoiWo Mak; Nuofu Zhang
Journal:  J Cell Mol Med       Date:  2018-03-07       Impact factor: 5.310

Review 9.  Regulation of Long Non-coding RNAs and MicroRNAs in Heart Disease: Insight Into Mechanisms and Therapeutic Approaches.

Authors:  Lucy Collins; Pablo Binder; Hongshan Chen; Xin Wang
Journal:  Front Physiol       Date:  2020-07-10       Impact factor: 4.566

Review 10.  Metabolic Flexibility as an Adaptation to Energy Resources and Requirements in Health and Disease.

Authors:  Reuben L Smith; Maarten R Soeters; Rob C I Wüst; Riekelt H Houtkooper
Journal:  Endocr Rev       Date:  2018-08-01       Impact factor: 19.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.